Affordable Access

deepdyve-link
Publisher Website

Intranasal corticosteroid administration reduces nonspecific bronchial hyperresponsiveness and improves asthma symptoms.

Authors
  • Agondi, Rosana Câmara
  • Machado, Maria Lavínea
  • Kalil, Jorge
  • Giavina-Bianchi, Pedro
Type
Published Article
Journal
Journal of Asthma
Publisher
Informa UK (Taylor & Francis)
Publication Date
Nov 01, 2008
Volume
45
Issue
9
Pages
754–757
Identifiers
DOI: 10.1080/02770900802249149
PMID: 18972290
Source
Medline
License
Unknown

Abstract

In this study, intranasal BDP was effective in treating rhinitis as well as asthma. The benefits for the lower airways were observed only after prolonged treatment and might be better evaluated through nonspecific bronchial challenge.

Report this publication

Statistics

Seen <100 times